Longicalycinin A cyclic analogue 2

General Information


DRACP ID  DRACP03729

Peptide Name   Longicalycinin A cyclic analogue 2

Sequence  LYPFA

Sequence Length  5

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C32H43N5O7

Absent amino acids  CDEGHIKMNQRSTVW

Common amino acids  AFLPY

Mass  68125

Pl  6.09

Basic residues  0

Acidic residues  0

Hydrophobic residues  3

Net charge  0

Boman Index  957

Hydrophobicity  110

Aliphatic Index  98

Half Life 
  Mammalian: 5.5 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  1490

Absorbance 280nm  372.5

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 31747558

Title  Structure-activity relationship studies of Longicalcynin A analogues, as anticancer cyclopeptides

Doi Not available

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  11976

DRACP is developed by Dr.Zheng's team.